UBS Group’s Nanobiotix NBTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Buy |
4,418
+1,418
| +47% | +$6.71K | ﹤0.01% | 7091 |
|
|
2025
Q1 | $10.7K | Sell |
3,000
-817
| -21% | -$2.93K | ﹤0.01% | 7290 |
|
|
2024
Q4 | $11K | Buy |
3,817
+717
| +23% | +$2.06K | ﹤0.01% | 7032 |
|
|
2024
Q3 | $17.8K | Hold |
3,100
| – | – | ﹤0.01% | 6228 |
|
|
2024
Q2 | $15.5K | Hold |
3,100
| – | – | ﹤0.01% | 6316 |
|
|
2024
Q1 | $20.2K | Hold |
3,100
| – | – | ﹤0.01% | 5757 |
|
|
2023
Q4 | $22.6K | Sell |
3,100
-706
| -19% | -$5.14K | ﹤0.01% | 5830 |
|
|
2023
Q3 | $33.3K | Sell |
3,806
-196
| -5% | -$1.72K | ﹤0.01% | 5406 |
|
|
2023
Q2 | $20.3K | Buy |
4,002
+1,002
| +33% | +$5.08K | ﹤0.01% | 5789 |
|
|
2023
Q1 | $10.6K | Sell |
3,000
-798
| -21% | -$2.81K | ﹤0.01% | 6474 |
|
|
2022
Q4 | $13.9K | Buy |
3,798
+755
| +25% | +$2.77K | ﹤0.01% | 6929 |
|
|
2022
Q3 | $11K | Buy |
3,043
+2
| +0.1% | +$7 | ﹤0.01% | 7209 |
|
|
2022
Q2 | $11K | Sell |
3,041
-778
| -20% | -$2.81K | ﹤0.01% | 6788 |
|
|
2022
Q1 | $26K | Sell |
3,819
-2,194
| -36% | -$14.9K | ﹤0.01% | 6113 |
|
|
2021
Q4 | $48K | Sell |
6,013
-54,340
| -90% | -$434K | ﹤0.01% | 5842 |
|
|
2021
Q3 | $686K | Buy |
60,353
+562
| +0.9% | +$6.39K | ﹤0.01% | 3523 |
|
|
2021
Q2 | $824K | Sell |
59,791
-10,391
| -15% | -$143K | ﹤0.01% | 3400 |
|
|
2021
Q1 | $1.06M | Buy |
70,182
+69,836
| +20,184% | +$1.05M | ﹤0.01% | 3306 |
|
|
2020
Q4 | $6K | Buy |
+346
| New | +$6K | ﹤0.01% | 6735 |
|